Mr. Dilip Kumar Tiwari
Director · PGDMM · 30 years
Strategic leadership and operational expertise driving Sucantis Biotech's quality-focused, growth-oriented approach.
About Us
Tiwari Group's forward integration into WHO-GMP pharmaceutical manufacturing — beta-lactam, cephalosporins and general formulations.
Our Company
Sucantis Biotech Private Limited
Established as the flagship manufacturing company of Tiwari Group, Sucantis Biotech delivers third-party and export formulations from dedicated beta-lactam, cephalosporin and general manufacturing blocks.
With ₹125 crore invested across Unit-1 (Haridwar) and Unit-2 (Kathua, J&K), we combine modern infrastructure, experienced leadership and rigorous quality systems for long-term CDMO partnerships.
- Unit-1 Haridwar — license obtained November 2023
- Unit-2 Kathua — license obtained May 2025
- Commercial production scaling across all ranges
Capacity
Manufacturing capability
| Dosage Form | Beta-Lactam | Cephalosporin | General |
|---|---|---|---|
| Tablets | 1500 million / annum | 1500 million / annum | 600 million / annum |
| Capsules | 300 million / annum | 200 million / annum | — |
| Dry Syrups | 20 million / annum | 20 million / annum | 5 million / annum |
Leadership
Board of Directors
Mr. Dhirendra Tiwari
Director · 16 years
Market dynamics, team management and distribution — ensuring strong domestic and export market presence.
Mr. Uma Kant Mishra
Director Technical · B.Pharma · 23 years
Product development and plant operations with Biogenetic Drugs and Associated Biotech; leads technical teams.
Mr. Ankur Tiwari
Director · B.Pharma · 3 years
Operations and product development involvement keeping offerings innovative and efficient.
Mr. Himanshu Shekhar Singh
Head — Quality Assurance · 16 years
QA leadership at Akums, Zydus and East African India; WHO-Geneva and multiple ROW regulatory inspections.
Mr. Hitender Verma
Head Quality — Unit-II · 20+ years
GLP & QMS expertise from Emcure, Lupin, Glenmark and Ranbaxy; USFDA, MHRA, EU and WHO experience.
Mission
What we stand for
Quality-first manufacturing
Every batch released through documented GMP controls — from vendor qualification to finished-goods testing.
Partner-centric CDMO model
Transparent timelines, regulatory documentation and dedicated blocks for beta-lactam and cephalosporin supply.
Domestic & global reach
Formulations for Indian pharma companies and export markets with neutral code and dossier support.
Process
How we work
Enquiry & feasibility
Product brief, regulatory scope and capacity alignment across beta, cepha or general blocks.
Tech transfer & validation
Formulation, stability and process validation under QA oversight.
Commercial production
Batch manufacturing with in-process controls and COA release.
Supply & documentation
Dispatch with batch records, certificates and export documentation as required.
Visit our Haridwar facility
We welcome serious manufacturing partners for plant visits and technical discussions.
Get in Touch